Evaluation of the PneumRx Lung Volume Reduction Coil to Treat Emphysema

Status Completed

Clinical Trial Summary

The objective of this study is to demonstrate the safety of the PneumRx Lung Volume Reduction Coil (LVRC) in a population of patients with emphysema. The PneumRx, Inc. LVRC is a used as a less invasive alternative to lung volume reduction surgery. The PneumRx LVRC is designed as an alternative to lung volume reduction surgery, potentially achieving the desired reduction in lung volume limiting the risks associated with major surgery, such as illness or death. This device is deployed through a bronchoscope and requires no incision.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01220908
Study type	Interventional
Source	Boston Scientific Corporation
Contact
Status	Completed
Phase	N/A
Start date	January 2008
Completion date	March 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05825261` - Exploring Novel Biomarkers for Emphysema Detection
Completed	`NCT02914340` - REACH SVS Control Patient Cross-Over Study	N/A
Completed	`NCT02999685` - Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients	N/A
Completed	`NCT02238327` - Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes
Completed	`NCT02232841` - Electrical Impedance Imaging of Patients on Mechanical Ventilation	N/A
Withdrawn	`NCT01908933` - Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema	Phase 3
Completed	`NCT01615484` - Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability	N/A
Completed	`NCT01476995` - Prognostic Indicators as Provided by the EPIC ClearView	N/A
Completed	`NCT01710449` - Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen	Phase 1
Completed	`NCT00475007` - Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema	N/A
Suspended	`NCT00523094` - Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure	N/A
Recruiting	`NCT00129350` - Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation	Phase 1
Completed	`NCT01953523` - Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions	N/A
Completed	`NCT00000621` - Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)	Phase 2
Completed	`NCT00005292` - Alpha1-antitrypsin Deficiency Registry	N/A
Recruiting	`NCT04537182` - Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema	N/A
Active, not recruiting	`NCT02713347` - Advancing Symptom Alleviation With Palliative Treatment	N/A
Recruiting	`NCT04302272` - STRIVE Post-Market Registry Study
Completed	`NCT04435327` - Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
Completed	`NCT03636347` - A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.	Phase 2